A high-throughput imaging workflow to spatially map Alzheimer's disease pathology in postmortem hippocampal and medial temporal lobe sections reveals region- and sex-specific patterns of pathology and neuro inflammation, offering new insights into mechanisms driving cognitive decline and informing future diagnostic and therapeutic strategies.
Abstract
We developed a high-throughput imaging workflow to spatially map Alzheimer’s disease (AD) pathology in postmortem hippocampal and medial temporal lobe sections from 65 University of Southern California Alzheimer's Disease Research Center (USC ADRC) cases classified by low, intermediate and high levels of AD neuropathologic change (ADNC). Sections were stained for microglia (Iba1), amyloid-β (4G8), and neurofibrillary tangles (NFTs; Gallyas), and analyzed using pixel-based machine learning (Ilastik). Amyloid pathology was classified as dense, diffuse, or intracellular amyloid precursor protein (APP)-positive; microglia were categorized into ramified, rod-like, and amoeboid morphologies. Diffuse amyloid plaques increased most significantly across disease, particularly in the subiculum and dentate gyrus molecular layer, while dense plaques and intracellular APP were concentrated in entorhinal and perirhinal cortices. NFT burden was elevated in males, especially in parahippocampal cortical areas. Microglial morphology shifted with AD progression, showing reduced ramified and increased amoeboid profiles in high ADNC cases. Rod microglia in CA regions were correlated with amyloid in high ADNC and tau in low ADNC cases. Memory impairment correlated more strongly with amyloid pathology in apolipoprotein E (ApoE) ε4 non-carriers, with females showing greater amyloid burden and males more NFT-related decline. These findings reveal region- and sex-specific patterns of pathology and neuroinflammation, offering new insights into mechanisms driving cognitive decline and informing future diagnostic and therapeutic strategies.
Amyloid beta (Aβ) deposition and tau accumulation are neuropathological hallmarks of Alzheimer’s disease (AD). While Aβ deposits present with a wide morphological variety, a comprehensive, cross-regional overview of Aβ plaque composition in AD and associations with clinicopathological traits are missing. In this study,...
Antonia Neubauer, Paul L. C. Feyen, S. Pekrun et al.· Acta Neuropathologica· 0 citations
Abstract INTRODUCTION Validation of Alzheimer's disease blood‐based biomarkers (BBMs) has relied largely on amyloid beta (Aβ) and tau positron emission tomography (PET), with limited quantitative neuropathologic correlation studies. We examined associations between BBMs and quantitative postmortem neuropathology in 124...
Celia R. Bianco, Neus Rabaneda-Lombarte, Hadia A. Fatima et al.· Alzheimer's & Dementia· 0 citations
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting more than 55 million people worldwide and is characterized by cognitive decline, amyloid-beta (Aβ) plaques, and neurofibrillary tangles. Although transgenic rodent models have advanced understanding of AD, they do not fully replicate the spo...
Abdullatif Alsulami, Marika Bogdani, Evan L. MacLean et al.· npj Dementia· 0 citations
MRI measures of cerebral blood flow and white matter hyperintensities differentiated NDAN from AD+MCI, highlighting vascular contributions to cognitive resilience, and CBF differentiated AD+MCI from Controls.
S. Fernandes‐Taylor, I. Driscoll, M. Glittenberg et al.· medRxiv· 0 citations
Mineralized blood vessels (MBV) are a form of vascular pathology associated with cerebrovascular aging and neurodegeneration; however, their regional distribution and clinicopathological correlates in Alzheimer disease (AD) remain poorly characterized. We examined 265 decedents with intermediate/high AD neuropathologic...
David Garcia, Naomi Saito, Shyam Tamizharasu et al.· Neurobiology of Aging· 0 citations
Altered CSF-vascular association was observed in Alzheimer's disease, suggesting possible glymphatic involvement, and the integration of CSF and vascular flow metrics provides a promising biomarker framework for early AD detection and monitoring.
Meng-Ying Lu, Yu-Shan Zheng, Ting-Ting Chen et al.· Journal of Visualized Experi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.